National Cancer Institute; Notice of Closed Meetings, 7452 [E9-3211]

Download as PDF 7452 Federal Register / Vol. 74, No. 30 / Tuesday, February 17, 2009 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, March 12, 2009, 8:30 a.m. to March 13, 2009, 5 p.m., Bethesda Marriott—Pooks Hill, 5151 Pooks Hill Road, Bethesda, MD, 20814 which was published in the Federal Register on January 12, 2009, 74 FR71219. This notice is amended to change the Scientific Review Officer from Rhonda J. Moore, PhD to Joyce C. Pegues, PhD. The meeting is closed to the public. Dated: February 9, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–3202 Filed 2–13–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings sroberts on PROD1PC70 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; Development of Molecular Pharmacodynamic Assays for Targeted Therapies. Date: March 19, 2009. Time: 10:30 a.m. to 1:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6116 Executive Boulevard, Conference Room 611, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Jeannette F. Korczak, PhD, Scientific Review Officer, Resources and Training Review Branch, Division of VerDate Nov<24>2008 19:45 Feb 13, 2009 Jkt 217001 Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8115, Bethesda, MD 20892, 301–496–9767, korczakj@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Affinity Capture Tools and Technology. Date: March 25, 2009. Time: 12:01 p.m. to 4 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6116 Executive Boulevard, Room 8018, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Caron Lyman, PhD, Scientific Review Officer, Division of Extramural Activities, Research Programs Review Branch, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8119, Bethesda, MD 20892–8328, 301–451–4761, lymanc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Multifunctional Therapeutics Based on Nanotechnology. Date: April 6–7, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: M Street Renaissance Hotel-Marriott, 1143 New Hampshire Avenue, NW., Washington, DC 20037. Contact Person: Irina V. Gordienko, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7073, Bethesda, MD 20892–8329, 301–594–1566, gordienkoiv@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: February 9, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–3211 Filed 2–13–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, March 3, 2009, 9 a.m. to March 3, 2009, 2 p.m., National Institutes of Health, 6116 Executive Blvd., Rockville, MD 20852 which was published in the Federal Register on January 12, 2009, 74 FR 71219. PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 This notice is amended to change the Scientific Review Officer from Rhonda J. Moore, PhD to Marvin L. Salin, PhD. The meeting is closed to the public. Dated: February 9, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–3237 Filed 2–13–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, March 24, 2009, 8 a.m. to March 24, 2009, 5 p.m., Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD, 20877 which was published in the Federal Register on January 29, 2009, 74FR5171. The meeting notice is changed to reflect the date change from March 24, 2009 to April 2, 2009. The meeting is closed to the public. Dated: February 10, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–3308 Filed 2–13–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Complementary & Alternative Medicine; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Alternative E:\FR\FM\17FEN1.SGM 17FEN1

Agencies

[Federal Register Volume 74, Number 30 (Tuesday, February 17, 2009)]
[Notices]
[Page 7452]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-3211]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Development of Molecular Pharmacodynamic Assays for Targeted 
Therapies.
    Date: March 19, 2009.
    Time: 10:30 a.m. to 1:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Conference Room 611, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Jeannette F. Korczak, PhD, Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 6116 
Executive Blvd., Room 8115, Bethesda, MD 20892, 301-496-9767, 
korczakj@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Affinity Capture Tools and Technology.
    Date: March 25, 2009.
    Time: 12:01 p.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 8018, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Caron Lyman, PhD, Scientific Review Officer, 
Division of Extramural Activities, Research Programs Review Branch, 
National Cancer Institute, NIH, 6116 Executive Blvd., Room 8119, 
Bethesda, MD 20892-8328, 301-451-4761, lymanc@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Multifunctional Therapeutics Based on Nanotechnology.
    Date: April 6-7, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: M Street Renaissance Hotel-Marriott, 1143 New Hampshire 
Avenue, NW., Washington, DC 20037.
    Contact Person: Irina V. Gordienko, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7073, Bethesda, MD 20892-8329, 301-594-1566, 
gordienkoiv@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-3211 Filed 2-13-09; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.